Journal ArticleOPEN ACCESS

Monoclonal antibodies for the treatment of severe asthma

  • Chaplin S
Prescriber (2020) 31(3) 23-28
DOI: 10.1002/psb.1830
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are now five monoclonal antibodies licensed as add‐on therapy for the treatment of severe asthma. This article provides an overview of their indications, efficacy, safety and place in therapy.

Cite

CITATION STYLE

APA

Chaplin, S. (2020). Monoclonal antibodies for the treatment of severe asthma. Prescriber, 31(3), 23–28. https://doi.org/10.1002/psb.1830

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free